Matt Britz
Amministratore Delegato presso Affyimmune Therapeutics, Inc.
Profilo
Matt Britz is currently the Chief Executive Officer at Affyimmune Therapeutics, Inc. He started this position in 2021 and it is ongoing.
Prior to his current role, he obtained a graduate degree from Washington University in St. Louis and an undergraduate degree from the University of Massachusetts.
Posizioni attive di Matt Britz
Società | Posizione | Inizio |
---|---|---|
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Amministratore Delegato | 19/03/2024 |
Formazione di Matt Britz
University of Massachusetts | Undergraduate Degree |
Washington University in St. Louis | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Commercial Services |
- Borsa valori
- Insiders
- Matt Britz